Company profile: Tx3
1.1 - Company Overview
Company description
- Provider of automated quality and compliance SaaS solutions for software testing within Life Science companies, enabling agile adoption and efficient adherence to regulatory requirements such as 21 CFR Part 11. Offerings include Tricentis Tosca, qTest, NeoLoad, LiveCompare, and Data Integrity.
Products and services
- Tricentis NeoLoad: Enterprise-grade performance testing tool that simplifies and scales performance testing across APIs, microservices, and end-to-end applications
- Tricentis qTest: Modular test management tool that centralizes test management activities, integrates with Agile and DevOps tools, and delivers visibility into testing activities
- Tricentis Tosca: Cross-application test automation platform supporting end-to-end testing across Salesforce, APIs, Oracle forms, and databases for comprehensive enterprise application coverage
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tx3
Biognosys
HQ: Switzerland
Website
- Description: Provider of integrated proteomics solutions and contract research services for pharma and biotech, including TrueDiscovery for deep, unbiased profiling across drug development, TrueTarget for drug target deconvolution and binding site mapping, TrueSignature custom panels for absolute protein quantification, Spectronaut mass spectrometry analysis software, and PQ500 kit for quantifying 500+ plasma proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biognosys company profile →
ZenQMS
HQ: United States
Website
- Description: Provider of cloud-based quality management software (eQMS) with modules for document management, training, issues, change control, and audits. Includes validation support with access to validation materials at no extra charge; a dashboard for compliance status, document access, and task completion; unlimited team access with no seat licenses; compliance with SOC II, ISO 27001, ISO 9001, GDPR, 21 CFR Part 11/Annex 11, and HIPAA; and customer support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZenQMS company profile →
Context Matters
HQ: United States
Website
- Description: Provider of a next-generation data platform linking drug development and market data, helping pharmaceutical companies access and understand complex data. Offers Cortellis Regulatory Intelligence covering global health authority requirements for human healthcare products (drugs, biologics, medical devices, IVDs) and Cortellis CMC Intelligence for CMC documentation, reducing regulatory delays and rejections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Context Matters company profile →
Mednet
HQ: United States
Website
- Description: Provider of eClinical solutions for the global life science community, specializing in their design within the healthcare sector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mednet company profile →
Clinical Insights
HQ: United Kingdom
Website
- Description: Provider of data-driven tools and business advisory services for pharmaceutical companies, leveraging dynamic analytical techniques and real-world, real-time market information to optimize performance, enhance market insights, and develop business solutions based on sophisticated analyses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Insights company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tx3
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tx3
2.2 - Growth funds investing in similar companies to Tx3
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tx3
4.2 - Public trading comparable groups for Tx3
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →